FR2359135A1 - Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique - Google Patents
Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutiqueInfo
- Publication number
- FR2359135A1 FR2359135A1 FR7720380A FR7720380A FR2359135A1 FR 2359135 A1 FR2359135 A1 FR 2359135A1 FR 7720380 A FR7720380 A FR 7720380A FR 7720380 A FR7720380 A FR 7720380A FR 2359135 A1 FR2359135 A1 FR 2359135A1
- Authority
- FR
- France
- Prior art keywords
- phenoxy
- lower alkyl
- substd
- propanolamine
- cardio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3064776 | 1976-07-22 | ||
GB5357676 | 1976-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2359135A1 true FR2359135A1 (fr) | 1978-02-17 |
Family
ID=26260544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7720380A Withdrawn FR2359135A1 (fr) | 1976-07-22 | 1977-07-01 | Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS5312851A (da) |
AU (1) | AU2714177A (da) |
DE (1) | DE2733305A1 (da) |
DK (1) | DK329577A (da) |
ES (1) | ES460866A1 (da) |
FR (1) | FR2359135A1 (da) |
GR (1) | GR61995B (da) |
NL (1) | NL7707949A (da) |
NO (1) | NO772604L (da) |
PT (1) | PT66781B (da) |
SE (1) | SE7708368L (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58160154U (ja) * | 1983-03-01 | 1983-10-25 | セイコーエプソン株式会社 | 印字装置 |
GB0319069D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Therapeutically useful compounds |
EP1737809B1 (en) | 2004-02-27 | 2013-09-18 | Amgen, Inc | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
US7465804B2 (en) | 2005-05-20 | 2008-12-16 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
WO2007033002A1 (en) | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
WO2008030520A1 (en) | 2006-09-07 | 2008-03-13 | Amgen Inc. | Heterocyclic gpr40 modulators |
US7687526B2 (en) | 2006-09-07 | 2010-03-30 | Amgen Inc. | Benzo-fused compounds for use in treating metabolic disorders |
US7572934B2 (en) | 2007-04-16 | 2009-08-11 | Amgen Inc. | Substituted biphenyl GPR40 modulators |
WO2009048527A1 (en) | 2007-10-10 | 2009-04-16 | Amgen Inc. | Substituted biphenyl gpr40 modulators |
JP2011515341A (ja) | 2008-03-06 | 2011-05-19 | アムジエン・インコーポレーテツド | 代謝障害の治療に有用な立体配座的に制限されたカルボン酸誘導体 |
AU2009303475B2 (en) | 2008-10-15 | 2012-09-13 | Amgen Inc. | Spirocyclic GPR40 modulators |
-
1977
- 1977-07-01 FR FR7720380A patent/FR2359135A1/fr not_active Withdrawn
- 1977-07-08 PT PT66781A patent/PT66781B/pt unknown
- 1977-07-09 GR GR53932A patent/GR61995B/el unknown
- 1977-07-15 NL NL7707949A patent/NL7707949A/xx not_active Application Discontinuation
- 1977-07-19 ES ES77460866A patent/ES460866A1/es not_active Expired
- 1977-07-19 AU AU27141/77A patent/AU2714177A/en active Pending
- 1977-07-20 SE SE7708368A patent/SE7708368L/xx unknown
- 1977-07-20 DK DK329577A patent/DK329577A/da unknown
- 1977-07-21 NO NO77772604A patent/NO772604L/no unknown
- 1977-07-21 DE DE19772733305 patent/DE2733305A1/de active Pending
- 1977-07-22 JP JP8826877A patent/JPS5312851A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO772604L (no) | 1978-01-24 |
GR61995B (en) | 1979-02-14 |
JPS5312851A (en) | 1978-02-04 |
SE7708368L (sv) | 1978-01-23 |
NL7707949A (nl) | 1978-01-24 |
PT66781B (fr) | 1978-12-18 |
DE2733305A1 (de) | 1978-01-26 |
ES460866A1 (es) | 1978-08-16 |
DK329577A (da) | 1978-01-23 |
AU2714177A (en) | 1979-01-25 |
PT66781A (fr) | 1977-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2359135A1 (fr) | Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique | |
AR241528A1 (es) | Un procedimiento para la preparacion de n-(3- o 4-((alquilamino)alquil)-fenil)alcansulfonamidas y sus sales. | |
FI935675A0 (fi) | Pyrazolopyrimidiner | |
NO843836L (no) | Terapeutisk aktive sulfamatderivater | |
FI860285A (fi) | 6-tioxantinderivat. | |
NO304787B1 (no) | Substituerte 1-okso-1,2-dihydro-isochinolinoyl- og 1,1-diokso-2H-1,2-benzotiazinoylguanidiner og anvendelse av forbindelsene for fremstilling av medikamenter | |
CA2003172A1 (en) | Certain 2-(2',3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones | |
MC1819A1 (fr) | Composes 4-benzyl-piperazinyl substitues | |
DK324886D0 (da) | Forgrenede polycarbonater indeholdende 2,4,6-tris(4'-hydroxyaryl)-amino-s-triaziner | |
CA1271199C (da) | ||
IT8419329A0 (it) | Pomata oleosa avente un'eccellente attivita' anti-infiammatoria. | |
DK189988A (da) | Pyridylalkansyreforbindelser med aktivitet som thromboxan a2-antagonister | |
FR2362115A1 (fr) | Nouveaux aryloxy-1 amino-3 propanols-2, leur preparation et leur utilisation, notamment en therapeutique | |
DK248484D0 (da) | Isoquinolinderivater | |
MC1281A1 (fr) | Agents diuretiques | |
FR2181527A1 (en) | 3-Phenoxy-1,2,5-thiadiazoles - with fungicidal activity | |
ES8500885A1 (es) | Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina | |
SE8202351L (sv) | Farmaceutiskt preparat | |
SU565494A1 (ru) | ω-орто-хлоранилид α-изобутил-β-метилглутаровой кислоты или его натриевая соль, проявляющие противовоспалительную и анальгезирующую активность | |
SU613592A1 (ru) | АЛКИЛОВЫЕ ЭФИРЫ ЦИКЛОГЕКСИЛ-β, β-ДИМЕТОКСИЭТИЛФОСФИНОВОЙ КИСЛОТЫ, ПРОЯВЛЯЮЩИЕ АНТИВИРУСНУЮ АКТИВНОСТЬ | |
FR2085633A1 (en) | Anti-inflammatory 3-dialkyl aminoalkoxy-1h-indazoles | |
ES414785A1 (es) | Procedimiento para la obtencion de composiciones fungicidasbasadas en anilidas de acidos 3-aminopropionicos. | |
FR2121447A2 (en) | Beta-adrenergic blocking aryloxy-prop - anolamines | |
FR2357549A1 (fr) | Triazoles substitues, leur preparation et leurs utilisations therapeutiques | |
SU1181283A1 (ru) | ДИГИДРОХЛОРИДЫ 2-ФЕНИЛ-4-β-ДИАЛКИЛАМИНОЭТИЛПИРАЗОЛО/1,5-а/БЕНЗИМИДАЗОЛОВ, ОБЛАДАЮЩИЕ АНТИАРИТМИЧЕСКОЙ И ГИПОТЕНЗИВНОЙ АКТИВНОСТЬЮ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Withdrawal of published application |